USPTO published an Intent to Use trademark application for 'LYME DISEASE TREATMENT CENTERS OF AMERICA' under Serial No. TM99200378. The trademark covers Class 044 medical services including Lyme disease treatment, designing treatment protocols for Lyme disease, and medical analysis services relating to patient treatment. The application asserts intent to use the mark in commerce by March 31, 2026.

Healthcare providers and medical practices offering Lyme disease treatment services should note this trademark filing for clearance purposes. Any entity considering using similar marks for Lyme disease medical services should conduct a trademark clearance search before adoption. This is a registration proceeding, not a compliance requirement—entities are not obligated to take action unless their operations may conflict with the claimed mark.